Methicillin-resistant Staphylococcus aureus (MRSA) has become the most commonly identified antibiotic-
resistant pathogen in the world. It is a significant cause of morbidity, mortality, and increased
healthcare costs. Stbc-ja-maljaaphylococcus aureus (SA) infections range from mild to life threatening.

When the infection has spread to the bloodstream, reliable results are needed fast. The immune response to bacteraemia can cause sepsis and septic shock, which result in a high rate of mortality despite intensive care. Additionally, culture remains a widely used method for screening but requires confirmation by other methods. GenomEra® MRSA/SA AC Test enables a definitive genetic diagnosis of MRSA or SA in less than one hour compared to hours or even days spent with conventional identification methods.

Due to the constant evolution of MRSA, it has also become increasingly important that the genetic tests cope with the different strains and manifestations of novel genotypes. One of the most significant of such variations is a divergent mecA gene, designated mecC. GenomEra® MRSA/SA AC Test detects both mecA and mecC genes ensuring comprehensive coverage of MRSA strains.

GenomEra® MRSA/SA AC Test enables testing both, blood cultures and plate samples using the same kit.

  • No sample preparation. Simple dilution of a droplet of blood culture or a colony.
  • Definitive genetic diagnosis of S. aureus and MRSA with the detection of both resistance genes (mecA/mecC).
  • Rapid turnaround time of 50 minutes for 4 results.

Excellent clinical performance with blood cultures (MRSA & SA combined, n=232):


GenomEra MRSA/SA AC Brochure